✦ LIBER ✦

DOV 216,303, a “Triple” Reuptake Inhibitor: Safety, Tolerability, and Pharmacokinetic Profile

✍ Scribed by Beer, Bernard; Stark, Jill; Krieter, Philip; Czobor, Pal; Beer, Gary; Lippa, Arnold; Skolnick, Phil

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Preclinical and Clinical Pharmacology of

✍ Phil Skolnick; Philip Krieter; Joseph Tizzano; Anthony Basile; Piotr Popik; Pal 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 123 KB

The putative antidepressant DOV 216,303,

✍ Jolanda Prins; Damiaan A. Denys; Koen G. Westphal; Gerdien A. Korte-Bouws; Maria 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 499 KB

The triple monoaminergic reuptake inhibi

✍ M.E. Breuer; J.S.W. Chan; R.S. Oosting; L. Groenink; S.M. Korte; U. Campbell; R. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 482 KB

The potential and limitations of DOV 216

✍ J. Prins; K.G.C. Westphal; G.A.H. Korte-Bouws; M.S. Quinton; R. Schreiber; B. Ol 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 915 KB

Safety, tolerability, and pharmacokineti

✍ B. Berger; A. Adedoyin; A. Marion 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 35 KB

Safety and tolerability of combined spec

✍ K. Chaleby; Yf. Semaan; S. Al Sughair 📂 Article 📅 1996 🏛 Elsevier Science 🌐 French ⚖ 132 KB